Cardiac reverse remodeling in the trial of accelerated guideline-directed medical therapy for Heart Failure (TEAM-HF)

14 May 2024 (09:06 - 09:14)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Laura Cohen

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

9 More presentations in this session

Presentation thumbnail

Transendocardial injection of autologous expanded CD34+ Stem Cells (ProtheraCytes) promotes reverse cardiac remodeling in patients with left ventricular dysfunction after acute myocardial infarction

Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Presentation thumbnail

Discussant review - EXCELLENT

Professor F. Gustafsson (Pleasanton, US)

Presentation thumbnail

Bio-ADM as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure; data from STRONG-HF

Mr G. Voordes (Groningen, NL)

Presentation thumbnail

Discussant review - STRONG-HF

Professor A. Bayes Genis (Badalona, ES)

Presentation thumbnail

Semaglutide and cardiovascular outcomes in patients with overweight or obesity and heart failure: A pre-specified analysis from the SELECT trial

Professor J. Deanfield (London, GB)

Access the full session

Session thumbnail

Late breaking clinical trials II

The Event

Event poster

Heart Failure 2024

14 May 2024 09:06 CET

You may be interested in

Congress Presentation

Discussant review - TEAM-HF: Cardiac Reverse Remodeling After Accelerated Implementation of Guideline-Directed Medical Heart Failure Therapy in a General Cardiology Clinic

Congress Presentation

First implementation results from the Trial for Evaluating Accelerated Guideline-Directed Medical Therapy for Heart Failure

Congress Presentation

Relationship between left ventricular reverse remodeling and guideline-directed medical therapy intensity in de novo heart failure with reduced ejection fraction patients: insight from TRANS-HF trial

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources